Nuvation Bio (NUVB) Stock: Buy, Sell, or Hold?
NUVB - Nuvation Bio Inc.
$4.55
-0.16 (-3.30%)
▼
5d:
+2.13%
30d:
-20.68%
90d:
-31.76%
HOLD
MODERATE Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 02, 2026
9d
Get Alerted When NUVB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NUVB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: NUVB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: NUVB is currently trading at $4.54, which is considered oversold relative to its 30-day fair value range of $4.73 to $5.79. From a valuation perspective, the stock is trading at a discount (Forward PE: -313.3) compared to its historical average (86.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NUVB is in a strong uptrend. Immediate support is located at $4.34, while resistance sits at $5.00. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $13.00 (+176.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NUVB is in a strong uptrend. Immediate support is located at $4.34, while resistance sits at $5.00. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $13.00 (+176.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.73 -
$5.79
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding NUVB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 176.6% below Wall St target ($13.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- NEUTRAL: Bottoming setup forming (43/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$4.73 -
$5.79
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.35
Resistance Level
$5.01
Current Trend
Strong Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-313.33
Wall Street Target
$13.00
(+176.6%)
Revenue Growth (YoY)
555.6%
Profit Margin
-88.2%
PE vs Historical
-313.3 vs 86.0
CHEAP
Share & Embed Analysis
Last updated: October 23, 2026 2:14 PM ET
Data refreshes hourly during market hours. Next update: 3:14 PM
Data refreshes hourly during market hours. Next update: 3:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUVB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 72 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 56 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
20 analysts |
$17 | 47 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
14 analysts |
$153 | 59 HOLD |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
15 analysts |
$108 | 61 BUY |
Advanced NUVB Option Strategies
Professional options setups generated by AI based on today's NUVB price and gamma walls.